Basaglar Follow-On Insulin Booms For Eli Lilly

 
• By Aidan Fry
  
DollarsGraph
Rapid volume uptake in the US is pushing Eli Lilly's Basaglar follow-on insulin towards blockbuster status • Source: Shutterstock

More from Earnings

More from Business